Edward M. Kaye MD - 23 Dec 2021 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
By: Robert Wong For: Edward M. Kaye
Issuer symbol
CYTK
Transactions as of
23 Dec 2021
Net transactions value
-$560,850
Form type
4
Filing time
23 Dec 2021, 18:11:04 UTC
Previous filing
04 Oct 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $114,150 +15,000 +222% $7.61* 21,765 23 Dec 2021 Direct F1, F2
transaction CYTK Common Stock Sale $675,000 -15,000 -69% $45.00 6,765 23 Dec 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (right to buy) Options Exercise $0 -15,000 -100% $0.000000* 0 23 Dec 2021 Common Stock 15,000 $7.61 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 12, 2021.
F2 Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.